World Pharma Newsfeed
Mayo Clinic researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer ...
AstraZeneca to streamline US sales organisation
AstraZeneca announced that it will reduce its US sales force by approximately 1,150 leadership positions and sales repre...
Prescribing Physicians, Patients and Institutions no Longer Required to Enroll in Nplate® NEXUS Program
Amgen (NASDAQ:AMGN) announced the U.S. Food and Drug Administration (FDA) has modified the requirements of the Nplate® (...
Plasma-based treatment goes viral
Life-threatening viruses such as HIV, SARS, hepatitis and influenza, could soon be combatted in an unusual manner as res...
Springer Healthcare Announces Agreement With ASCO®
Springer Healthcare, part of Springer Science+Business Media, has signed an extensive three-year reprints and sales agre...
Pfizer Completes Acquisition of Excaliard
Pfizer Inc. (NYSE: PFE) has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceu...
Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals
Bristol-Myers Squibb Company (NYSE:BMY) has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals...
Novartis Foundation symposium looks at impact of Information and Communication Technology
Today a panel of experts in media, technology and healthcare are gathering to discuss the topic "New media - drivers of ...
Understand Barriers to Progression of Insulin Treatment
Eli Lilly and Company (NYSE: LLY) is conducting the first major international, prospective observational study designed ...
FDA approves first generic version of cholesterol-lowering drug Lipitor
The U.S. Food and Drug Administration approved the first generic version of the cholesterol-lowering drug Lipitor (atorv...
